MGLG (MGLG) Stock Price & Analysis
MGLG (MGLG) rose 0.00% to USD 0 as of June 10, 2026 at 06:42 UTC, according to Nexqual real-time market data.
MGLG last closed at USD 0; the session ranged USD 0–0 on volume of 10,720,000 shares. Market capitalization is —, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 06:42 UTC.
Key Statistics (as of June 10, 2026 at 06:42 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 10,720,000 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (MGLG)
Nexqual's technical model rates MGLG "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 06:42 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (MGLG)
Wall Street analysts rate MGLG "None", per Nexqual as of June 10, 2026 at 06:42 UTC.
| Consensus Rating | None |
|---|
Earnings (MGLG)
Source: Nexqual, June 10, 2026 at 06:42 UTC.
Financials & Fundamentals (MGLG)
| Total Revenue | $32.67M |
|---|---|
| Revenue Growth (YoY) | -32.00% |
| Gross Margin | +16.55% |
| Operating Margin | -3.92% |
| Profit Margin | -15.69% |
| ROE | -98.94% |
| Debt / Equity | 260.08 |
| Current Ratio | 0.71 |
| Total Cash | $594,115 |
| Total Debt | $10.82M |
| Free Cash Flow | $2.61M |
Source: Nexqual, June 10, 2026 at 06:42 UTC.
Financial Health Score (MGLG)
Nexqual rates MGLG's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:42 UTC.
| Growth | Critical — Revenue -32% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $594K cash vs $11M debt |
| Cash Flow | Solid — FCF $3M, 8% margin |
| Efficiency | Critical — ROE -99%, ROA -4.6% |
Ownership (MGLG)
| Shares Outstanding | 7.80B |
|---|
Source: Nexqual, June 10, 2026 at 06:42 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMNE | AMERICAN GREEN GROUP INC | USD 0 | ▲ 0% |
| HTDS | HARD TO TREAT DISEASES INC | USD 0 | ▲ 0% |
| PHMB | PHARMACOM BIOVET INC | USD 0 | ▲ 0% |
| IGNT | INGEN TECHNOLOGIES INC | USD 0 | ▲ 0% |
| ASFX | AMERICAN SCIENTIFIC RESOURCES I | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:42 UTC. This page is informational and not investment advice.